# CELLTRAZONE CO., LTD

FEI: 3013500651
Status: Active
Establishment types: Manufacture Medical Device
Owner/operator: Celltrazone Co., Ltd (#10053102)

Address: 1F, 6F, 16, ARAYUK-RO, GOCHON-EUP, GIMPO-SI Seoul, 10136, KR

Mandatory US Agent: KMC USA, Inc

## Products

Total registered: 1
Top product codes: LDZ
Regulation §: 864.4010

Proprietary names: HURO PATH® Solution (Body Fluid) - BULK, HURO PATH® Solution (Body Fluid), HURO PATH® Solution (Non-GYN) - BULK, HURO PATH® Lysis Solution (Contro-reagent), HURO PATH® Solution (Diluent), HURO PATH® Solution (GYN) - BULK, HURO PATH® Lysis Solution (Hemolics), HURO PATH® Solution (FNA) - BULK, HURO PATH® Solution (Urine) - BULK, HURO PATH® Solution (SPUTUM) - BULK

## Source

- openFDA: https://api.fda.gov/device/registrationlisting.json?search=registration.fei_number:%223013500651%22
- FDA Registration Lookup: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?lid=3013500651